4 completed, 1 active not recruiting, 1 recruiting. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Completed 2 |
Follow Mohammed Milhem: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors 5 Azacytidine, Pembrolizumab, Nivolumab - Solid Tumor, Locally Advanced Solid Tumor | Phase 1 | Recruiting | Mohammed Milhem | 35 | 2026-02-11 | 2026-05-28 |
| Chlorpromazine and Standard of Care in Glioblastoma Chlorpromazine, Temozolomide, Radiation Therapy - Glioblastoma Multiforme | Phase 1 | Completed | Mohammed Milhem | 10 | 2022-01-28 | 2025-09-02 |
| High Dose Ascorbate With Preoperative Radiation in Patients With Locally Advanced Soft Tissue Sarcomas Ascorbate - Soft Tissue Sarcoma | Phase 1 / Phase 2 | Completed | Mohammed Milhem | 25 | 2019-06-27 | 2026-06-18 |
| Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial Zoledronic Acid - Chondrosarcoma | Phase 1 | Active not recruiting | Mohammed Milhem | 17 | 2017-07-18 | 2025-11-06 |
| Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma Decitabine, Gemcitabine - Pancreatic Ductal Adenocarcinoma, Sarcoma | Phase 1 | Completed | Mohammed Milhem | 36 | 2016-12-05 | 2023-07-28 |
| SLM + Axitinib for Clear Cell RCC Selenomethionine (SLM), Axitinib - Advanced Metastatic Clear Cell Renal Cell Carcinoma (CCRCC) | Phase 1 / Phase 2 | Completed | Mohammed Milhem | 45 | 2016-01-01 | 2026-05-06 |
Sarcoma (2) · Chondrosarcoma (1) · Glioblastoma (1) · Kidney Neoplasms (1) · Neoplasm Metastasis (1)
Ascorbic Acid (1) · Axitinib (1) · Azacitidine (1) · Chlorpromazine (1) · Decitabine (1) · Gemcitabine (1) · Nivolumab (1) · Radiotherapy (1) · Selenomethionine (1) · Temozolomide (1) · Zoledronic Acid (1) · cemiplimab (1) · pembrolizumab (1)
United States (6)